Dr. Gregory Steven Gesell, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 17th Ave E, Alexandria, MN 56308 Phone: 320-762-1511 Fax: 320-762-6101 |
Mitchell Gesell, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 17th Ave E, Alexandria, MN 56308 Phone: 320-762-1511 Fax: 320-762-6101 |
David J. Odland, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1527 Broadway St, Alexandria, MN 56308 Phone: 320-762-0399 |
Dr. Dane Jason Mitteness, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 17th Ave E, Alexandria, MN 56308 Phone: 320-762-1511 |
Benjamin Andrew Kitt, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 17th Ave E, Alexandria, MN 56308 Phone: 320-762-1511 Fax: 320-762-6070 |
News Archive
USAID Administrator Rajiv Shah on Wednesday at the Food Security Investment Forum outlined U.S. plans for its food security partnership with Bangladesh as part of the Feed the Future initiative, the Daily Star reports. The goal of the two-day forum was "to help Bangladesh finalise a roadmap for future investments in food and agriculture," the publication writes (5/27).
Omega-3 essential fatty acid supplementation is unnecessary for adolescent girls with eating disorders and weight-loss eating disorder, as levels normalize once they return to normal weight, say researchers.
An international research team led by members of the University of Colorado School of Medicine faculty has identified a genetic connection between rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis.
Desperation led José Luis Hernández to ride atop a speeding train through northern Mexico with hopes of reaching the United States 13 years ago.
Pharmasset, Inc. announced today that dosing has begun in an exploratory study of PSI-7977, a nucleotide analog polymerase inhibitor, for the treatment of chronic hepatitis C (HCV). The trial will evaluate PSI-7977 400mg QD in combination with ribavirin (RBV), with 0, 4, 8, or 12 weeks of pegylated interferon alfa 2a (Peg-IFN) in treatment-naive patients infected with HCV genotype 2 or 3.
› Verified 2 days ago